InMed Pharmaceuticals (INM) Price & Analysis

Q: What was InMed Pharmaceuticals’s price range in the past 12 months?

InMed Pharmaceuticals lowest stock price was $1.72 and its highest was $8.27 in the past 12 months.

Q: What is InMed Pharmaceuticals’s market cap?

InMed Pharmaceuticals’s market cap is $5.22M.

Q: When is InMed Pharmaceuticals’s upcoming earnings report date?

InMed Pharmaceuticals’s upcoming earnings report date is Nov 13, 2025 which is in 46 days.

Q: How were InMed Pharmaceuticals’s earnings last quarter?

InMed Pharmaceuticals released its earnings results on Sep 23, 2025. The company reported -$0.893 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.893.

Q: Is InMed Pharmaceuticals overvalued?

According to Wall Street analysts InMed Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does InMed Pharmaceuticals pay dividends?

InMed Pharmaceuticals does not currently pay dividends.

Q: What is InMed Pharmaceuticals’s EPS estimate?

InMed Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does InMed Pharmaceuticals have?

InMed Pharmaceuticals has 2,384,186 shares outstanding.

Q: What happened to InMed Pharmaceuticals’s price movement after its last earnings report?

InMed Pharmaceuticals reported an EPS of -$0.893 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.727%.

Q: Which hedge fund is a major shareholder of InMed Pharmaceuticals?

Currently, no hedge funds are holding shares in INM

Compare

380 Followers

INM Stock Chart & Stats

Day’s Range― - ―

52-Week Range$1.72 - $8.27

Previous CloseN/A

Volume49.03K

Average Volume (3M)61.85K

Market Cap

$5.22M

Enterprise Value-$3.87M

Total Cash (Recent Filing)$11.12B

Total Debt (Recent Filing)$305.75M

Price to Earnings (P/E)―

Beta2.78

Next Earnings

Nov 13, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.89

Shares Outstanding2,384,186

10 Day Avg. Volume105,470

30 Day Avg. Volume61,851

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)<0.01

Price to Sales (P/S)0.00064

P/FCF Ratio-0.41

Enterprise Value/Market Cap-0.74

Enterprise Value/Revenue>-0.01

Enterprise Value/Gross Profit>-0.01

Enterprise Value/Ebitda<0.01

Forecast

1Y Price Target

$2.50

Price Target Upside14.16% Upside

Rating ConsensusModerate Sell

Number of Analyst Covering0

InMed Pharmaceuticals News

Trump links Tylenol use to autism, AutoZone reports downbeat Q4: Morning Buzz

The major averages were mixed near noon as traders continue to monitor the recent market rally, as well...

5d ago

InMed Pharmaceuticals reports FY25 EPS ($8.36) vs ($20.14) last year

Reports FY25 revenue $4.9M vs $4.6M last year. The Company expects its cash will be sufficient to fund...

5d ago

INM

InMed Pharmaceuticals: Advancing Cannabinoid-Based Therapies

Inmed Pharmaceuticals Inc. ( ($INM) ) has released its Q4 earnings. Here is a breakdown of the information...

5d ago

INM

InMed Pharmaceuticals Advances Alzheimer’s Program with Promising Results

An announcement from InMed Pharmaceuticals ( ($INM) ) is now available. InMed Pharmaceuticals reported its fiscal year 2025...

5d ago

INM

InMed Pharmaceuticals to Showcase Pipeline Progress at Global Investment Conference

An update from InMed Pharmaceuticals ( ($INM) ) is now available. InMed Pharmaceuticals announced its participation in the...

23d ago

INM

InMed Pharmaceuticals to Present Promising INM-901 Data at AAIC 2025

InMed Pharmaceuticals ( ($INM) ) just unveiled an update. InMed Pharmaceuticals announced the presentation of new preclinical data...

2M ago

INM

InMed Pharmaceuticals files to sell 3.9M common shares for holders

17:29 EDT InMed Pharmaceuticals (INM) files to sell 3.9M common shares for holders Published first on TheFly –...

3M ago

INM

InMed Pharmaceuticals Secures $5M in Private Placement

InMed Pharmaceuticals ( ($INM) ) has shared an announcement. On June 24, 2025, InMed Pharmaceuticals entered into a...

3M ago

INM

InMed Pharmaceuticals Secures $5 Million in Private Placement to Advance Drug Pipeline

InMed Pharmaceuticals ( ($INM) ) just unveiled an announcement. InMed Pharmaceuticals announced the closing of a $5 million...

3M ago

INM

InMed Pharmaceuticals Secures $5 Million in Private Placement to Advance Drug Development

InMed Pharmaceuticals ( ($INM) ) has issued an announcement. InMed Pharmaceuticals announced a $5 million private placement with...

3M ago

INM

InMed Pharmaceuticals announces $5M private placement

InMed Pharmaceuticals (INM) announced that it has entered into definitive agreements with a single institutional investor for the...

3M ago

INM

Morning Movers: TD Synnex slips following second quarter results

Stock futures are up following a surprise ceasefire announcement between Israel and Iran by President Trump, although there...

3M ago

CCL

InMed Pharmaceuticals announces new preclinical data on INM-901

InMed Pharmaceuticals (INM) announced new preclinical data demonstrating that INM-901 significantly reduces inflammation in ex vivo models of...

3M ago

INM

InMed’s INM-901 Shows Promise in Reducing Alzheimer’s Neuroinflammation

InMed Pharmaceuticals ( ($INM) ) has provided an update. InMed Pharmaceuticals announced promising preclinical results for its drug...

3M ago

INM

INM FAQ

What was InMed Pharmaceuticals’s price range in the past 12 months?

InMed Pharmaceuticals lowest stock price was $1.72 and its highest was $8.27 in the past 12 months.

What is InMed Pharmaceuticals’s market cap?

InMed Pharmaceuticals’s market cap is $5.22M.

When is InMed Pharmaceuticals’s upcoming earnings report date?

InMed Pharmaceuticals’s upcoming earnings report date is Nov 13, 2025 which is in 46 days.

How were InMed Pharmaceuticals’s earnings last quarter?

InMed Pharmaceuticals released its earnings results on Sep 23, 2025. The company reported -$0.893 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.893.

Is InMed Pharmaceuticals overvalued?

According to Wall Street analysts InMed Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does InMed Pharmaceuticals pay dividends?

InMed Pharmaceuticals does not currently pay dividends.

What is InMed Pharmaceuticals’s EPS estimate?

InMed Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does InMed Pharmaceuticals have?

InMed Pharmaceuticals has 2,384,186 shares outstanding.

What happened to InMed Pharmaceuticals’s price movement after its last earnings report?

InMed Pharmaceuticals reported an EPS of -$0.893 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.727%.

Which hedge fund is a major shareholder of InMed Pharmaceuticals?

Currently, no hedge funds are holding shares in INM

Company Description

InMed Pharmaceuticals

InMed Pharmaceuticals (INM) is a biopharmaceutical company focused on the research, development, and commercialization of novel, cannabinoid-based therapeutics. Operating within the pharmaceutical sector, InMed specializes in the manufacturing and development of rare cannabinoids and advanced cannabinoid-based treatments with a focus on various unmet medical needs.